Literature DB >> 27487957

Characterization of Vibrio cholerae Strains Isolated from the Nigerian Cholera Outbreak in 2010.

Susann Dupke1, Kehinde A Akinsinde2, Roland Grunow1, Bamidele A Iwalokun2, Daniel K Olukoya3, Afolabi Oluwadun4, Thirumalaisamy P Velavan5, Daniela Jacob6.   

Abstract

We examined clinical samples from Nigerian patients with acute watery diarrhea for Vibrio cholerae during the 2010 cholera outbreak. A total of 109 suspected isolates were characterized, but only 57 V. cholerae strains could be confirmed using multiplex real-time PCR as well as rpoB sequencing and typed as V. cholerae O:1 Ogawa biotype El Tor. This finding highlighted the need for accurate diagnosis of cholera in epidemic countries to implement life-saving interventions.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27487957      PMCID： PMC5035406          DOI： 10.1128/JCM.01467-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  26 in total

1.  Serotype variation in vibrio cholerae el tor diarrhoea in northern Nigeria.

Authors:  G C Onyemelukwe; R V Lawande
Journal:  Cent Afr J Med       Date:  1991-06

2.  Rapid identification and characterization of Vibrio species using whole-cell MALDI-TOF mass spectrometry.

Authors:  R Dieckmann; E Strauch; T Alter
Journal:  J Appl Microbiol       Date:  2009-12-07       Impact factor: 3.772

3.  Detection and differentiation of Vibrio spp. in seafood and fish samples with cultural and molecular methods.

Authors:  U Messelhäusser; J Colditz; D Thärigen; W Kleih; C Höller; U Busch
Journal:  Int J Food Microbiol       Date:  2010-07-17       Impact factor: 5.277

4.  Detecting and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction.

Authors:  S P Keasler; R H Hall
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

5.  Non-O1 Vibrio cholerae septicemia: case report, discussion of literature, and relevance to bioterrorism.

Authors:  Albert M L Anderson; Jay B Varkey; Cathy A Petti; Rodger A Liddle; Richard Frothingham; Christopher W Woods
Journal:  Diagn Microbiol Infect Dis       Date:  2004-08       Impact factor: 2.803

6.  Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site.

Authors:  D Cassel; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

7.  Evolutionary genetic analysis of the emergence of epidemic Vibrio cholerae isolates on the basis of comparative nucleotide sequence analysis and multilocus virulence gene profiles.

Authors:  Yvonne A O'Shea; F Jerry Reen; Anne Marie Quirke; E Fidelma Boyd
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Cholera outbreaks in Africa.

Authors:  Martin A Mengel; Isabelle Delrieu; Leonard Heyerdahl; Bradford D Gessner
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  Multi-locus variable number tandem repeat analysis of 7th pandemic Vibrio cholerae.

Authors:  Connie Lam; Sophie Octavia; Peter R Reeves; Ruiting Lan
Journal:  BMC Microbiol       Date:  2012-05-24       Impact factor: 3.605

10.  Genotypic and PFGE/MLVA analyses of Vibrio cholerae O1: geographical spread and temporal changes during the 2007-2010 cholera outbreaks in Thailand.

Authors:  Kazuhisa Okada; Amonrattana Roobthaisong; Ichiro Nakagawa; Shigeyuki Hamada; Siriporn Chantaroj
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240
View more
  2 in total

Review 1.  Recurrent cholera epidemics in Africa: which way forward? A literature review.

Authors:  Abraham Ajayi; Stella I Smith
Journal:  Infection       Date:  2018-08-06       Impact factor: 3.553

2.  Epidemiology, diagnostics and factors associated with mortality during a cholera epidemic in Nigeria, October 2020-October 2021: a retrospective analysis of national surveillance data.

Authors:  Kelly Elimian; Sebastian Yennan; Anwar Musah; Iliya Danladi Cheshi; Carina King; Lauryn Dunkwu; Ahmed Ladan Mohammed; Eme Ekeng; Oluwatosin Wuraola Akande; Stephanie Ayres; Benjamin Gandi; Emmanuel Pembi; Fatima Saleh; Ahmed Nasir Omar; Emily Crawford; Olubunmi Omowumi Olopha; Robinson Nnaji; Basheer Muhammad; Rejoice Luka-Lawal; Adachioma Chinonso Ihueze; David Olatunji; Chidimma Ojukwu; Afolabi Muftau Akinpelu; Ene Adaga; Yusuf Abubakar; Ifeoma Nwadiuto; Samuel Ngishe; Agnes Bosede Alowooye; Peace Chinma Nwogwugwu; Khadeejah Kamaldeen; Henry Nweke Abah; Egbuna Hyacinth Chukwuebuka; Hakeem Abiola Yusuff; Ibrahim Mamadu; Abbas Aliyu Mohammed; Sarah Peter; Okpachi Christopher Abbah; Popoola Michael Oladotun; Santino Oifoh; Micheal Olugbile; Emmanuel Agogo; Nnaemeka Ndodo; Olajumoke Babatunde; Nwando Mba; John Oladejo; Elsie Ilori; Tobias Alfvén; Puja Myles; Chinwe Lucia Ochu; Chikwe Ihekweazu; Ifedayo Adetifa
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.